Cantor Fitzgerald, L. P. »

Arcutis Biotherapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2023-12-31 $33k 10k 3.23
2023-06-30 $542k 57k 9.53

More positions owned by Cantor Fitzgerald, L. P.

Acelrx Pharmaceuticals Com New (TLPH)
Ramaco Res Com Cl A (METC)
Gcm Grosvenor Com Cl A (GCMG)
Senseonics Hldgs (SENS)
Rumble Com Cl A (RUM)
22nd Centy Group Com New (XXII)
Proshares Tr Ultrapro Qqq (TQQQ)
Xbp Europe Holdings (XBP)
Wework Cl A New (WEWKQ)
Moneyhero Ord Shs (MNY)
Meta Platforms Cl A (META)
Satellogic Class A Ord Shs (SATL)
GSK Sponsored Adr (GSK)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics